6533b830fe1ef96bd12979dc
RESEARCH PRODUCT
64. EORTC-1203: Integration of trastuzumab, with or without pertuzumab, into perioperative chemotherapy of HER-2 positive stomach cancer: INNOVATION EudraCT number 2014-000722-38; NCT02205047
Anna Dorothea WagnerFlorian LordickJ.m. Van DierenChristoph SchuhmacherJ.w. Van SandickManuel Salto-tellezCarmela CaballeroKozo KataokaHeike I. GrabschMarkus MöhlerMurielle MauerN.c.t. Van GriekenAjlan AtasoyRupert LangerJae Yong ChoYoon-koo KangArnaud Rothsubject
0301 basic medicineOncologymedicine.medical_specialtybusiness.industryGeneral Medicinemedicine.disease03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyTrastuzumab030220 oncology & carcinogenesisPerioperative chemotherapyInternal medicinemedicineSurgeryPertuzumabStomach cancerbusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2016-09-01 | European Journal of Surgical Oncology (EJSO) |